{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:03:09Z","timestamp":1776423789927,"version":"3.51.2"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K16351"],"award-info":[{"award-number":["22K16351"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11593"],"award-info":[{"award-number":["24K11593"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ek0410138"],"award-info":[{"award-number":["JP25ek0410138"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Akita University Key Research Laboratory Fund"},{"DOI":"10.13039\/100014423","name":"Environmental Restoration and Conservation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Granulomatosis with polyangiitis (GPA) is traditionally regarded as a neutrophil-driven necrotizing vasculitis. However, the potential involvement of eosinophilic inflammation has not been fully elucidated. We investigated the contribution of eosinophilic inflammation to the pathogenesis of GPA, with a particular focus on eosinophil extracellular trap formation (EETosis). This retrospective study included 52 patients, including 25 with active GPA and 27 in remission. We recorded enzyme-linked immunosorbent assay\u2013based serum concentrations of eosinophil-derived proteins (galectin-10, eosinophil cationic protein, and eosinophil-derived neurotoxin), neutrophil-derived proteins (myeloperoxidase), and a marker for extracellular traps (citrullinated histone H3) for these patients. EETosis in tissue samples of patients was examined by immunofluorescence staining. Serum-induced EETosis was evaluated in vitro. Serum concentrations of galectin-10, eosinophil cationic protein, eosinophil-derived neurotoxin, citrullinated histone H3, and C-reactive protein and antineutrophil cytoplasmic antibody titre of patients with active GPA were significantly higher than those in remission. Galectin-10 had the strongest correlation with the Birmingham Vasculitis Activity Score (r = 0.778, P &amp;lt; 0.001). Increased galectin-10 levels were identified to be associated with the active stage after adjustment for glucocorticoid dose and eosinophil count. Receiver operating characteristic analyses of galectin-10 to discriminate between the active and remission phases revealed an area under the curve of 0.923, with 85.2% sensitivity and 91.1% specificity. GPA lung tissue showed lytic eosinophils and EETosis. Additionally, serum from active GPA patients induced EETosis in vitro whereas that from remission patients did not. Eosinophil activation and EETosis may contribute to the disease activity of GPA, highlighting a previously underrecognized component of its pathogenesis.<\/jats:p>","DOI":"10.1093\/cei\/uxag010","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T12:20:52Z","timestamp":1771244452000},"source":"Crossref","is-referenced-by-count":0,"title":["Eosinophils ETosis as a novel contributor to the pathogenesis of granulomatosis with polyangiitis"],"prefix":"10.1093","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0779-2608","authenticated-orcid":false,"given":"Teppei","family":"Hashimoto","sequence":"first","affiliation":[{"name":"Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University , Nishinomiya ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3537-7735","authenticated-orcid":false,"given":"Shigeharu","family":"Ueki","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine , Akita ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0306-3443","authenticated-orcid":false,"given":"Shohei","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine , Akita ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5650-7834","authenticated-orcid":false,"given":"Keinosuke","family":"Hizuka","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine , Akita ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahoko","family":"Kodama","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine , Akita ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Minagawa","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University , Nishinomiya ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University , Nishinomiya ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University , Nishinomiya ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University , Nishinomiya ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Hirota","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, School of Medicine, Hyogo Medical University , Nishinomiya ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4773-1535","authenticated-orcid":false,"given":"Naoto","family":"Azuma","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University , Nishinomiya ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1146-4172","authenticated-orcid":false,"given":"Kiyoshi","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University , Nishinomiya ,","place":["Japan"]},{"name":"Department of Rheumatology, Amagasaki Central Hospital , Amagasaki ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2026041706081640600_uxag010-B1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(23)01736-1","article-title":"Diagnosis and management of ANCA-associated vasculitis","volume":"403","author":"Kronbichler","year":"2024","journal-title":"Lancet"},{"key":"2026041706081640600_uxag010-B2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026041706081640600_uxag010-B3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-147-9-200711060-00005","article-title":"Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis","volume":"147","author":"Finkielman","year":"2007","journal-title":"Ann Intern Med"},{"key":"2026041706081640600_uxag010-B4","first-page":"S38","article-title":"Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener\u2019s) may reflect treatment rather than disease activity","volume":"31","author":"Rasmussen","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"2026041706081640600_uxag010-B5","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/art.39637","article-title":"Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3","volume":"68","author":"Fussner","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026041706081640600_uxag010-B6","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/rheumatology\/keu427","article-title":"Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis","volume":"54","author":"Grayson","year":"2015","journal-title":"Rheumatol (Oxf Engl)"},{"key":"2026041706081640600_uxag010-B7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1568-9972(03)00010-7","article-title":"Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides","volume":"2","author":"Csernok","year":"2003","journal-title":"Autoimmun Rev"},{"key":"2026041706081640600_uxag010-B8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat Med"},{"key":"2026041706081640600_uxag010-B9","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"2026041706081640600_uxag010-B10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrneph.2017.37","article-title":"Complement in ANCA-associated vasculitis: mechanisms and implications for management","volume":"13","author":"Chen","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2026041706081640600_uxag010-B11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","article-title":"Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease","volume":"10","author":"Jennette","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"2026041706081640600_uxag010-B12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"key":"2026041706081640600_uxag010-B13","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/art.41727","article-title":"Eosinophil ETosis-mediated release of galectin-10 in eosinophilic granulomatosis with polyangiitis","volume":"73","author":"Fukuchi","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2026041706081640600_uxag010-B14","doi-asserted-by":"crossref","first-page":"801897","DOI":"10.3389\/fimmu.2021.801897","article-title":"Increased circulating cell-free DNA in eosinophilic granulomatosis with polyangiitis: implications for eosinophil extracellular traps and immunothrombosis","volume":"12","author":"Hashimoto","year":"2022","journal-title":"Front Immunol"},{"key":"2026041706081640600_uxag010-B15","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1182\/blood-2012-05-432088","article-title":"Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans","volume":"121","author":"Ueki","year":"2013","journal-title":"Blood"},{"key":"2026041706081640600_uxag010-B16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13075-023-03233-1","article-title":"Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis","volume":"25","author":"Ha","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"2026041706081640600_uxag010-B17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1164\/ajrccm.161.2.9904076","article-title":"Activation of neutrophils, eosinophils, and lymphocytes in the lower respiratory tract in Wegener\u2019s granulomatosis","volume":"161","author":"Schnabel","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026041706081640600_uxag010-B18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2026041706081640600_uxag010-B19","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score. version 3","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2026041706081640600_uxag010-B20","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2018-04-842260","article-title":"Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death","volume":"132","author":"Ueki","year":"2018","journal-title":"Blood"},{"key":"2026041706081640600_uxag010-B21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.alit.2020.10.002","article-title":"How to detect eosinophil ETosis (EETosis) and extracellular traps","volume":"70","author":"Fukuchi","year":"2021","journal-title":"Allergol Int"},{"key":"2026041706081640600_uxag010-B22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1165\/rcmb.2023-0438OC","article-title":"Characteristics and regulation of human eosinophil ETosis in vitro","volume":"72","author":"Tomizawa","year":"2025","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026041706081640600_uxag010-B23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.41982","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis","volume":"74","author":"Grayson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026041706081640600_uxag010-B24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.41986","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for rheumatology classification criteria for granulomatosis with polyangiitis","volume":"74","author":"Robson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026041706081640600_uxag010-B25","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3390\/biom12101385","article-title":"Galectin-10 as a potential biomarker for eosinophilic diseases","volume":"12","author":"Tomizawa","year":"2022","journal-title":"Biomolecules"},{"key":"2026041706081640600_uxag010-B26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41927-019-0059-6","article-title":"Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis","volume":"3","author":"Hellmark","year":"2019","journal-title":"BMC Rheumatol"},{"key":"2026041706081640600_uxag010-B27","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.5415\/apallergy.2021.11.e30","article-title":"Eosinophil-mediated inflammation in the absence of eosinophilia","volume":"11","author":"Miyabe","year":"2021","journal-title":"Asia Pac Allergy"},{"key":"2026041706081640600_uxag010-B28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/JLB.3AB0220-311R","article-title":"Galectin-10, the protein that forms Charcot-Leyden crystals, is not stored in granules but resides in the peripheral cytoplasm of human eosinophils","volume":"108","author":"Melo","year":"2020","journal-title":"J Leukoc Biol"},{"key":"2026041706081640600_uxag010-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2020.04.021","article-title":"Eosinophil responses during COVID-19 infections and coronavirus vaccination","volume":"146","author":"Lindsley","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2026041706081640600_uxag010-B30","doi-asserted-by":"crossref","first-page":"1261151","DOI":"10.3389\/fimmu.2023.1261151","article-title":"The involvement of NETs in ANCA-associated vasculitis","volume":"14","author":"Shiratori-Aso","year":"2023","journal-title":"Front Immunol"},{"key":"2026041706081640600_uxag010-B31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/rccm.201804-0809OC","article-title":"Sputum antineutrophil cytoplasmic antibodies in serum antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis","volume":"199","author":"Mukherjee","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026041706081640600_uxag010-B32","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.intimp.2007.07.006","article-title":"The role of the complement anaphylatoxins in the recruitment of eosinophils","volume":"7","author":"DiScipio","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"2026041706081640600_uxag010-B33","doi-asserted-by":"publisher","DOI":"10.22541\/au.174768134.49131571\/v1","article-title":"Complement-eosinophil axis participates in fibrin deposition in eosinophilic chronic rhinosinusitis","author":"Imoto","year":"2025","journal-title":"Authorea [Preprint]"},{"key":"2026041706081640600_uxag010-B34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3899\/jrheum.160005","article-title":"Comparison of the phenotype and outcome of granulomatosis with polyangiitis between UK and Japanese cohorts","volume":"44","author":"Furuta","year":"2017","journal-title":"J Rheumatol"},{"key":"2026041706081640600_uxag010-B35","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/art.39812","article-title":"Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive and ANCA-negative patients with granulomatosis with polyangiitis (Wegener\u2019s): distinct patient subsets","volume":"68","author":"Miloslavsky","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026041706081640600_uxag010-B36","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/art.39786","article-title":"Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive granulomatosis with polyangiitis (Wegener\u2019s) is a clinically distinct subset of ANCA-associated vasculitis: a retrospective analysis of 315 patients from a German vasculitis referral center","volume":"68","author":"Schirmer","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026041706081640600_uxag010-B37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.kint.2023.03.029","article-title":"Assessment of longitudinal serum neutrophil extracellular trap-inducing activity in anti-neutrophil cytoplasmic antibody-associated vasculitis and glomerulonephritis in a prospective cohort using a novel bio-impedance technique","volume":"104","author":"Aendekerk","year":"2023","journal-title":"Kidney Int"},{"key":"2026041706081640600_uxag010-B38","first-page":"792","article-title":"Application of the 2022 ACR\/EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis","volume":"41","author":"Pyo","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"2026041706081640600_uxag010-B39","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/rheumatology\/keac267","article-title":"Reclassification of previously diagnosed GPA patients using the 2022 ACR\/EULAR classification criteria","volume":"62","author":"Pyo","year":"2023","journal-title":"Rheumatol (Oxf Engl)"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxag010\/66958696\/uxag010.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/220\/1\/uxag010\/68104496\/uxag010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/220\/1\/uxag010\/68104496\/uxag010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:08:26Z","timestamp":1776420506000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/doi\/10.1093\/cei\/uxag010\/8488684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxag010","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"uxag010"}}